Delivery Order SPE2DB24D2100-SPE2DB24FBCKK

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of IMOVAX Rabies Vaccine vials. The $2,281.90 fixed-price delivery order was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD). The contract has an ultimate completion date of August 16, 2023. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,158.70 firm-fixed price delivery order is for the supply of IMOVAX Rabies Vaccine vials. The contract has an ultimate completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,238.05 firm fixed price Delivery Order is for the supply of IMOVAX Rabies Vaccine Vials. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $4,317.40 firm-fixed-price contract is for the delivery of IMOVAX Rabies Vaccine vials, with a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine vials. The contract has a potential value of $5,267.14 and a completion date of February 21, 2024. This award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,166.50, is for the delivery of IMOVAX Rabies Vaccine Vials. This is a firm fixed-price Delivery Order contract with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,456.37 firm fixed-price delivery order is for the provision of IMOVAX Rabies Vaccine Vials. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract, valued at $3,669.79, is for the provision of IMOVAX Rabies Vaccine vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,004.75 firm fixed-price delivery order is for the supply of IMOVAX Rabies Vaccine Vials. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCKK
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,801.92 firm-fixed-price delivery order is for the supply of IMOVAX rabies vaccine vials, with a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/11/24, 9:37 AM